Tocilizumab Cuts Progression to Ventilation or Death in COVID-19
But death from any cause by day 28 in those hospitalized with COVID-19 pneumonia did not differ for tocilizumab versus placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.